Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 1018796, 8 pages
https://doi.org/10.1155/2017/1018796
Research Article

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects

1Department of Nutrition, School of Public Health, University of Sao Paulo, São Paulo, SP, Brazil
2Department of Experimental Physics, Institute of Physics, University of Sao Paulo, São Paulo, SP, Brazil

Correspondence should be addressed to Nágila R. T. Damasceno

Received 20 March 2017; Revised 31 May 2017; Accepted 13 June 2017; Published 22 August 2017

Academic Editor: Joseph F. Ndisang

Copyright © 2017 Flávia De C. Cartolano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Himsworth, “Diabetes mellitus: its differentiation into insulin sensitive and insulin insensitive types,” The Lancet, vol. 227, pp. 127–130, 1936. View at Google Scholar
  2. C. R. Kahn, “Insulin action, diabetogenes, and the cause of type II diabetes,” Diabetes, vol. 43, pp. 1066–1084, 1994. View at Google Scholar
  3. G. M. Reaven, “Insulin resistance: the link between obesity and cardiovascular disease,” The Medical Clinics of North America, vol. 95, pp. 875–892, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Ferrannini, “The insulin resistance syndrome,” Current Opinion in Nephrology & Hypertension, vol. 1, pp. 291–298, 1992. View at Google Scholar
  5. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, 6th edition, 2014, June 2016, http://www.idf.org/diabetesatlas.
  6. E. Ferrannini, S. M. Haffner, B. D. Mitchell, and M. P. Stern, “Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome,” Diabetologia, vol. 34, pp. 416–422, 1991. View at Google Scholar
  7. G. M. Reaven, “Pathophysiology of insulin resistance in human disease,” Physiological Reviews, vol. 75, pp. 473–486, 1995. View at Google Scholar
  8. R. H. Unger, “Reinventing type 2 diabetes: pathogenesis, treatment, and prevention,” The Journal of the American Medical Association, vol. 299, pp. 1185–1187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Reaven, “Insulin resistance and coronary heart disease in nondiabetic individuals,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, pp. 1754–1759, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Li, J. Fu, D. P. Koonen, J. A. Kuivenhoven, H. Snieder, and M. H. Hofker, “Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?” Atherosclerosis, vol. 233, pp. 130–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. Mackey, S. Mora, A. G. Bertoni et al., “Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis,” Diabetes Care, vol. 38, pp. 628–636, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. W. T. Garvey, S. Kwon, D. Zheng et al., “Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance,” Diabetes, vol. 52, pp. 453–462, 2003. View at Google Scholar
  13. P. S. MacLean, S. Vadlamudi, K. G. MacDonald, W. J. Pories, J. A. Houmard, and H. A. Barakat, “Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women,” Metabolism, vol. 49, pp. 285–292, 2000. View at Google Scholar
  14. A. Festa, K. Williams, A. J. Hanley et al., “Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study,” Circulation, vol. 111, pp. 3465–3472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Milech, A. P. Angelucci, A. Golbert, A. J. Carrilho, A. C. Ramalho, and A. C. Aguiar, Diretrizes da Sociedade Brasileira de Diabetes (2015-2016), A.C. Farmacêutica, São Paulo, 2016, orgnization José Egidio Paulo de Oliveira, Sérgio Vencio.
  16. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, pp. 499–402, 1972. View at Google Scholar
  17. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, pp. 412–419, 1985. View at Google Scholar
  18. S. E. Stern, K. Williams, E. Ferrannini, R. A. DeFronzo, C. Bogardus, and M. P. Stern, “Identification of individuals with insulin resistance using routine clinical measurements,” Diabetes, vol. 54, pp. 333–339, 2005. View at Google Scholar
  19. R. A. DeFronzo and E. Ferrannini, “Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease,” Diabetes Care, vol. 14, pp. 173–194, 1991. View at Google Scholar
  20. C. Packard, M. Caslake, and J. Shepherd, “The role of small, dense low density lipoprotein (LDL): a new look,” International Journal of Cardiology, vol. 74, Supplement 1, pp. S17–S22, 2000. View at Google Scholar
  21. K. K. Berneis and R. M. Krauss, “Metabolic origins and clinical significance of LDL heterogeneity,” Journal of Lipid Research, vol. 43, pp. 1363–1379, 2002. View at Google Scholar
  22. M. R. Diffenderfer and E. J. Schaefer, “The composition and metabolism of large and small LDL,” Current Opinion in Lipidology, vol. 25, pp. 221–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Shah, W. S. Davidson, Z. Gao, L. M. Dolan, T. R. Kimball, and E. M. Urbina, “Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes,” Journal of Clinical Lipidology, vol. 10, pp. 610–618, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Arca, G. Pigna, and C. Favoccia, “Mechanisms of diabetic dyslipidemia: relevance for atherogenesis,” Current Vascular Pharmacology, vol. 10, pp. 684–686, 2012. View at Google Scholar
  25. G. Steiner and M. Vranic, “Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential,” International Journal of Obesity, vol. 6, Supplement 1, pp. 117–124, 1982. View at Google Scholar
  26. A. von Eckardstein and R. A. Sibler, “Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2,” Current Opinion in Lipidology, vol. 22, pp. 26–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. G. Drew, K. A. Rye, S. J. Duffy, P. Barter, and B. A. Kingwell, “The emerging role of HDL in glucose metabolism,” Nature Reviews Endocrinology, vol. 8, pp. 237–245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Wu and K. G. Parhofer, “Diabetic dyslipidemia,” Metabolism, vol. 63, pp. 1469–1479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Adiels, S. O. Olofsson, M. R. Taskinen, and J. Borén, “Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, pp. 1225–1236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. D. Otvos, E. J. Jeyarajah, D. W. Bennett, and R. M. Krauss, “Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement,” Clinical Chemistry, vol. 38, no. 9, pp. 1632–1638, 1992. View at Google Scholar
  31. P. J. Barter, R. Puranik, and K. A. Rye, “New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease,” Current Cardiology Reports, vol. 9, pp. 493–498, 2007. View at Google Scholar
  32. C. R. Sirtori, L. Calabresi, G. Franceschini et al., “Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study,” Circulation, vol. 103, pp. 1949–1954, 2001. View at Google Scholar
  33. R. S. Rosenson, H. B. Brewer, B. Ansell et al., “Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges,” Circulation, vol. 128, pp. 1256–1267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Pirillo, G. D. Norata, and A. L. Catapano, “High-density lipoprotein subfractions—what the clinicians need to know,” Cardiology, vol. 124, pp. 116–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Glomset, “The plasma lecithins:cholesterol acyltransferase reaction,” Journal of Lipid Research, vol. 9, pp. 155–167, 1968. View at Google Scholar
  36. A. Kontush and M. J. Chapman, “Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities,” Current Opinion in Lipidology, vol. 21, pp. 312–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Tian, L. Jia, F. Mingde et al., “Alterations of high density lipoprotein subclasses in obese subjects,” Lipids, vol. 41, pp. 789–796, 2006. View at Google Scholar
  38. F. M. Sacks and H. Campos, “Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, pp. 4525–4532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Lamarche, I. Lemieux, and J. P. Després, “The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects,” Diabetes & Metabolism, vol. 25, pp. 199–211, 1999. View at Google Scholar
  40. D. M. Hoefner, D. S. Hodel, J. F. O’Brien et al., “Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system,” Clinical Chemistry, vol. 47, pp. 266–274, 2001. View at Google Scholar
  41. E. Bonora, G. Targher, M. Alberiche et al., “Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity,” Diabetes Care, vol. 23, pp. 57–63, 2000. View at Google Scholar
  42. R. A. DeFronzo, J. D. Tobin, and R. Andres, “The glucose clamp technique: a method for quantifying insulin secretion and resistance,” The American Journal of Physiology, vol. 237, pp. E214–E223, 1979. View at Google Scholar
  43. P. Gayoso-Diz, A. Otero-González, M. X. Rodriguez-Alvarez et al., “Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study,” Diabetes Research and Clinical Practice, vol. 94, pp. 146–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Gayoso-Diz, A. Otero-González, M. X. Rodriguez-Alvarez et al., “Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study,” BMC Endocrine Disorders, vol. 13, p. 47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C. H. Lee, A. Z. L. Shih, Y. C. Woo et al., “Optimal cut-offs of homeostasis model assessment of insulin resistance (HOMA-IR) to identify dysglycemia and type 2 diabetes mellitus: a 15-year prospective study in Chinese,” PLoS One, vol. 11, article e0163424, 2016. View at Google Scholar
  46. P. M. McKeigue, B. Shah, and M. G. Marmot, “Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians,” Lancet, vol. 337, pp. 382–386, 1991. View at Google Scholar
  47. M. A. Banerji, N. Faridi, R. Atluri, R. L. Chaiken, and H. E. Lebovitz, “Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men,” The Journal of Clinical Endocrinology and Metabolism, vol. 84, pp. 137–144, 1999. View at Publisher · View at Google Scholar